Published on 4/13/2006 in the Prospect News PIPE Daily.
New Issue: AspenBio Pharma settles $1.428 million private placement of stock
By Sheri Kasprzak
New York, April 13 - AspenBio Pharma, Inc. said it concluded a $1.428 million private placement with accredited investors that bought 1.02 million shares at $1.40 each.
Proceeds will be used for product development, working capital and general corporate purposes.
AspenBio Pharma is based in Castle Rock, Colo., and produces bovine pregnancy tests for the agricultural industry.
| Issuer: | AspenBio Pharma, Inc.
|
| Issue: | Stock
|
| Amount: | $1. 428 million
|
| Shares: | 1.02 million
|
| Price: | $1.40
|
| Warrants: | No
|
| Settlement date: | April 13
|
| Stock symbol: | OTCBB: APNB
|
| Stock price: | $1.52 at close April 12
|
|
|
© 2015 Prospect News.
All content on this website is protected by copyright law in the U.S. and elsewhere.
For the use of the person downloading only.
Redistribution and copying are prohibited by law without written permission in advance from Prospect News.
Redistribution or copying includes e-mailing, printing multiple copies or any other form of reproduction.
